NCT04936308 2026-03-12
SOLSTICE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
Clinical Trials
8 trialsNCT06641089 2026-03-11
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3 Recruiting
NCT05413044 2025-12-08
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Bristol-Myers Squibb
Completed
NCT05421442 2025-12-08
DANBIO
Bristol-Myers Squibb
Completed
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT03162796 2021-02-03
Discover-1
Janssen Research & Development, LLC
Phase 3 Completed
NCT02028169 2017-04-27
To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
AbbVie
Completed
NCT01519089 2015-08-13
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Pfizer
Phase 3 Completed